Experimental Hematology and Oncology
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherBMC
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesEUR 2590 | USD 2990 | GBP 2290
- Publication Time6
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2012
- Publisher URL
- Website URL
- Plagiarism
- Publication Time6
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC0
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 26% |
| 4-6 | 49% |
| 7-9 | 20% |
| >9 | 5% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Experimental Hematology and Oncology been publishing? 
The Experimental Hematology and Oncology has been publishing since 2012 till date.
How frequently is the Experimental Hematology and Oncology published?
Experimental Hematology and Oncology is published Continuous publication.
Who is the publisher of Experimental Hematology and Oncology?
The publisher of Experimental Hematology and Oncology is BMC.
How can I view the journal metrics of Experimental Hematology and Oncology on editage?
For the Experimental Hematology and Oncology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Experimental Hematology and Oncology?
The eISSN number is 2162-3619 and pISSN number is 2162-3619 for Experimental Hematology and Oncology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Hepatocellular carcinoma, Notch signaling pathway, Bone marrow, Protein kinase A, Maximum tolerated dose, Overall survival, Photopheresis, Chimeric antigen receptor, Peripheral T-cell lymphoma, Post-transcriptional regulation, Arsenic, Diffuse large B-cell lymphoma, Clinical trial, Cell therapy, Fusion gene, Polycythemia vera, Immunotherapy, Phosphoglycerate dehydrogenase, Burden of disease, Untranslated region.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.